Back to search

Article

Disease-modifying effects of Vincamine supplementation in <i>Drosophila</i> and human cell models of Parkinson’s disease

2022-12-29

Abstract excerpt

<h4>ABSTRACT</h4> Parkinson’s disease (PD) is an incurable neurodegenerative disorder caused by the selective loss of dopaminergic neurons in the substantia nigra pars compacta . Current therapies are only symptomatic, and are not able to stop or delay its progression. In order to search new and more effective therapies, our group carried out a high-throughput screening assay, identifying several candidate compo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1690d559-48a6-5991-acb5-e42adc215870
DOI
10.1101/2022.12.28.522104
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Disease-modifying effects of Vincamine supplementation in <i>Drosophila</i> and human cell models of Parkinson’s diseaseDOI 10.1101/2022.12.28.522104
Evaluation of potential neuroprotective effects of Vanillin against MPP+/MPTP-induced dysregulation of dopaminergic regulatory mechanisms in SH-SY5Y cells and a mouse model of Parkinson's diseaseSemantic proximity
Evaluation of potential neuroprotective effects of Vanillin against MPP+/MPTP-induced dysregulation of dopaminergic regulatory mechanisms in SH-SY5Y cells and Parkinson's disease mice modelSemantic proximity
Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.Semantic proximity
Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s DiseaseSemantic proximity
Neuroprotective potential of an <i>Ayurvedic</i> compound “Ras-Sindoor” on <i>Drosophila melanogaster</i> model of Parkinson’s diseaseSemantic proximity
Identification of structural features of selected flavonoids responsible for neuroprotection using a <i>Drosophila</i> model of Parkinson’s diseaseSemantic proximity
Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and <i>Drosophila melanogaster</i> model of Alzheimer’s diseaseSemantic proximity
Enhanced activity of glycolytic enzymes in <i>Drosophila</i> and human cell models of Parkinson’s disease based on <i>DJ-1</i> deficiencySemantic proximity
Plants and phytochemicals for Huntington′s diseaseSemantic proximity
Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson’s Disease TherapySemantic proximity
Exploring the link between Parkinson’s disease and Diabetes Mellitus in <i>Drosophila</i>Semantic proximity
Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s diseaseSemantic proximity
Select a neighboring publication to make it the new centre.